WHAT & WHY: The agenda for the Optimizing PCI Outcomes: A Vision for 2012 symposium is now available at: http://www.pcioutcomes.com/conference/agenda.html. This evening symposium will feature the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease, including the latest clinical data on current and second-generation drug-eluting stent device-based therapies. Controversies, including resistance and selection, of antiplatelet therapy as adjunctive treatment with percutaneous intervention will be discussed along with the use of imaging tools and how to manage complex lesions.
Presentations will focus on:
- The Case for Surgery and the Case for PCI In Patients with Complex Coronary Artery Disease
- The Appropriateness of PCI Procedures
- Optimizing Pharmacology Before, During, and After PCI
- Prevention and Treatment of Stent Thrombosis
- Complex PCI: Technique, Tips, and Tricks
WHEN:
Friday, March 23, 2012
5:30 PM-9:30 PM
WHERE:
Swiss-tel Chicago
323 East Wacker Drive
Chicago, IL
PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease